Literature DB >> 27015639

Correction: Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Naïve to Antiretroviral Therapy: A Pilot Randomized Trial.

Sergio Serrano-Villar, Talia Sainz, Zhong-Min Ma, Netanya S Utay, Tae-Wook Chun, Surinder Mann, Angela D Kashuba, Basile Siewe, Anthony Albanese, Paolo Troia-Cancio, Elizabeth Sinclair, Anoma Somasunderam, Tammy Yotter, Steven G Deeks, Alan Landay, Richard B Pollard, Christopher J Miller, Santiago Moreno, David M Asmuth.   

Abstract

Entities:  

Year:  2016        PMID: 27015639      PMCID: PMC4807777          DOI: 10.1371/journal.ppat.1005540

Source DB:  PubMed          Journal:  PLoS Pathog        ISSN: 1553-7366            Impact factor:   6.823


× No keyword cloud information.
  1 in total

1.  Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Naïve to Antiretroviral Therapy: A Pilot Randomized Trial.

Authors:  Sergio Serrano-Villar; Talia Sainz; Zhong-Min Ma; Netanya S Utay; Tae-Wook Chun; Tae Wook-Chun; Surinder Mann; Angela D Kashuba; Basile Siewe; Anthony Albanese; Paolo Troia-Cancio; Elizabeth Sinclair; Anoma Somasunderam; Tammy Yotter; Steven G Deeks; Alan Landay; Richard B Pollard; Christopher J Miller; Santiago Moreno; David M Asmuth
Journal:  PLoS Pathog       Date:  2016-01-21       Impact factor: 6.823

  1 in total
  6 in total

1.  Lower Pretreatment Gut Integrity Is Independently Associated With Fat Gain on Antiretroviral Therapy.

Authors:  Vanessa El Kamari; Carlee Moser; Corrilynn O Hileman; Judith S Currier; Todd T Brown; Liz Johnston; Peter W Hunt; Grace A McComsey
Journal:  Clin Infect Dis       Date:  2019-04-08       Impact factor: 9.079

2.  Association between a Suppressive Combined Antiretroviral Therapy Containing Maraviroc and the Hepatitis B Virus Vaccine Response.

Authors:  Inés Herrero-Fernández; Yolanda M Pacheco; Ezequiel Ruiz-Mateos; Manuel Leal; Miguel Genebat; María Del Mar Rodriguez-Méndez; María Del Carmen Lozano; María José Polaino; Isaac Rosado-Sánchez; Laura Tarancón-Diez; María Ángeles Muñoz-Fernández
Journal:  Antimicrob Agents Chemother       Date:  2017-12-21       Impact factor: 5.191

Review 3.  Zonulin, a regulator of epithelial and endothelial barrier functions, and its involvement in chronic inflammatory diseases.

Authors:  Craig Sturgeon; Alessio Fasano
Journal:  Tissue Barriers       Date:  2016-10-21

4.  Improved CD4 T cell profile in HIV-infected subjects on maraviroc-containing therapy is associated with better responsiveness to HBV vaccination.

Authors:  Inés Herrero-Fernández; Isaac Rosado-Sánchez; Miguel Genebat; Laura Tarancón-Díez; María Mar Rodríguez-Méndez; María Mar Pozo-Balado; Carmen Lozano; Ezequiel Ruiz-Mateos; Manuel Leal; Yolanda M Pacheco
Journal:  J Transl Med       Date:  2018-08-29       Impact factor: 5.531

Review 5.  Targeting CCR5 as a Component of an HIV-1 Therapeutic Strategy.

Authors:  Hager Mohamed; Theodore Gurrola; Rachel Berman; Mackenzie Collins; Ilker K Sariyer; Michael R Nonnemacher; Brian Wigdahl
Journal:  Front Immunol       Date:  2022-01-20       Impact factor: 7.561

6.  Increased CD127+ and decreased CD57+ T cell expression levels in HIV-infected patients on NRTI-sparing regimens.

Authors:  A Gonzalez-Serna; S Ferrando-Martinez; L Tarancon-Diez; R S De Pablo-Bernal; B Dominguez-Molina; J L Jiménez; M Á Muñoz-Fernández; M Leal; E Ruiz-Mateos
Journal:  J Transl Med       Date:  2017-12-20       Impact factor: 5.531

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.